PTGS2 and prostate cancer: Multiple follow-up studies revealed that PTGS2 (COX-2) levels are elevated in other premalignant and malignant solid tumors, including stomach, esophagus, liver, pancreas, head and neck, lung, breast, and prostate cancer [7].